Portfolio company
Sensei Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops multi-node pathway inhibitors and immunotherapy treatments for cancer patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
D3 Bio
This biotechnology company develops precision medicines and oncology therapeutics for patients with cancer and immunological conditions.
Siren Bio
This company develops immuno-gene therapies combining viral gene delivery and cytokine immunotherapy to treat solid tumours for cancer patients.
Laguna Bio
This company develops engineered microbial therapies that activate the immune system to treat cancer patients.
Waypoint Bio
This company develops cell therapies for solid tumours using a spatial biology and machine learning platform to assist patients with difficult-to-treat cancers.
Haptena Therapeutics
This biotechnology company develops immunotherapies for patients with oncogene-driven cancers by integrating precision oncology with immune engineering.
Ribon Therapeutics
This biotechnology company develops small molecule inhibitors targeting stress support pathways for patients with cancer and inflammatory diseases.
Fore Bio
This biotechnology company develops precision oncology therapies and small-molecule inhibitors for patients with unaddressed tumour mutations and hard-to-treat cancers.
Senti Biosciences
This clinical-stage biotechnology company develops programmable cell and gene therapies using synthetic biology and gene circuits to treat patients with cancer and incurable diseases.
